伊藤 文隆

Medicine & Life Sciences

1. Brachytherapy 100%
2. Seeds 92%
3. Prostate 64%
4. GABA-A Receptors 58%
5. Iodine-125 51%
6. Microglia 40%
7. PK 11195 34%
8. Ethanol 33%
9. (R)-(11C)1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide 32%
10. Prostatic Neoplasms 30%
11. Ligands 27%
12. Radiation Pneumonitis 25%
13. Positron-Emission Tomography 21%
14. Learning Curve 21%
15. Pets 20%
16. Wounds and Injuries 18%
17. Single-Photon Emission-Computed Tomography 18%
18. Animals 18%
19. Survival Analysis 17%
20. Urinary Bladder Neoplasms 17%
21. Lipopolysaccharides 15%
22. Brain Injuries 15%
23. Pneumonia 14%
24. Radiotherapy 12%
25. Prostate-Specific Antigen 12%
26. Health Care Outcome Assessment 11%
27. Breast Neoplasms 11%
28. Survival 10%
29. Urethra 7%
30. Incidence 7%
31. Recurrence 6%
32. Staining and Labeling 6%
33. Chloral Hydrate 5%
34. Interleukin-1 5%